mulTiplex Immunoassay qualiTy assuRance Panel

Collection of serum from women not living with HIV, who received the GBS6 vaccine in the "a placebo-controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants" (GBS6) Clinical Trial in Kampala, Uganda, for the Development of Group B Streptococcus quality assurance panel for the GASTON multiplex anti-CPS IgG immunoassay

NCT Number	NCT07562061
Lead Sponsor	St George's, University of London
Conditions	Group B Strep Infection
Enrollment	50 participants
Start Date	2026-03-27
Primary Completion	2026-05 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-01